
### [MONDO:0018882](http://purl.obolibrary.org/obo/MONDO_0018882)
**Label:** vasculitis

**Subclasses:** [MONDO:0015488](http://purl.obolibrary.org/obo/MONDO_0015488) (predominantly large-vessel vasculitis), [MONDO:0019170](http://purl.obolibrary.org/obo/MONDO_0019170) (polyarteritis nodosa), [MONDO:0015489](http://purl.obolibrary.org/obo/MONDO_0015489) (predominantly medium-vessel vasculitis), [MONDO:0018640](http://purl.obolibrary.org/obo/MONDO_0018640) (secondary vasculitis), [MONDO:0017991](http://purl.obolibrary.org/obo/MONDO_0017991) (Takayasu arteritis), [MONDO:0015491](http://purl.obolibrary.org/obo/MONDO_0015491) (immune complex mediated vasculitis), [MONDO:0015490](http://purl.obolibrary.org/obo/MONDO_0015490) (predominantly small-vessel vasculitis), [MONDO:0015492](http://purl.obolibrary.org/obo/MONDO_0015492) (Anti-neutrophil cytoplasmic antibody-associated vasculitis), [MONDO:0018593](http://purl.obolibrary.org/obo/MONDO_0018593) (primary polyarteritis nodosa), [MONDO:0007407](http://purl.obolibrary.org/obo/MONDO_0007407) (Cryoglobulinemic vasculitis), [MONDO:0014306](http://purl.obolibrary.org/obo/MONDO_0014306) (vasculitis due to ADA2 deficiency), 

**Corr. equiv. classes:** [Orphanet:445197](http://www.orpha.net/ORDO/Orphanet_445197), [Orphanet:156149](http://www.orpha.net/ORDO/Orphanet_156149), [Orphanet:156146](http://www.orpha.net/ORDO/Orphanet_156146), [Orphanet:156152](http://www.orpha.net/ORDO/Orphanet_156152), [Orphanet:156143](http://www.orpha.net/ORDO/Orphanet_156143), [OMIM:123550](http://purl.obolibrary.org/obo/OMIM_123550), [Orphanet:156140](http://www.orpha.net/ORDO/Orphanet_156140), [Orphanet:91138](http://www.orpha.net/ORDO/Orphanet_91138), [Orphanet:439737](http://www.orpha.net/ORDO/Orphanet_439737), [OMIM:615688](http://purl.obolibrary.org/obo/OMIM_615688), [OMIM:207600](http://purl.obolibrary.org/obo/OMIM_207600), [Orphanet:767](http://www.orpha.net/ORDO/Orphanet_767), [Orphanet:3287](http://www.orpha.net/ORDO/Orphanet_3287), [Orphanet:404553](http://www.orpha.net/ORDO/Orphanet_404553), 

**Class expressions from DL-Learner:**

- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 22.32%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 21.60%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 21.30%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 20.73%
- [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) 20.08%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 19.70%
- Thing 19.69%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 19.69%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 18.87%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 18.53%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) 18.50%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 18.40%
- [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 18.21%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 17.94%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 17.27%


